UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Development of a neonatal adverse event severity scale through a Delphi consensus approach

Archives of disease in childhood, 2019-12, Vol.104 (12), p.1167

2019

Volltextzugriff (PDF)

Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study

Journal of sexual medicine, 2017-11, Vol.14 (11), p.1307-1317

2017

Volltextzugriff (PDF)

Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men

Journal of sexual medicine, 2016-08, Vol.13 (8), p.1220-1226

2016

Volltextzugriff (PDF)

Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2

Journal of sexual medicine, 2016-08, Vol.13 (8), p.1212-1219

2016

Volltextzugriff (PDF)

Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men: Ejaculatory Function

Journal of sexual medicine, 2016-08, Vol.13 (8), p.1220-1226

2016

Volltextzugriff (PDF)

Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2%: Endocrinology

Journal of sexual medicine, 2016-08, Vol.13 (8), p.1212-1219

2016

Volltextzugriff (PDF)

Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study

The Journal of urology, 2016-03, Vol.195 (3), p.699

2016

Volltextzugriff (PDF)

Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study

Journal of pediatric hematology/oncology, 2015-01, Vol.37 (1), p.1-9

2015

Volltextzugriff (PDF)

Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study

Blood, 2012-11, Vol.120 (21), p.3213-3213

2012

Volltextzugriff (PDF)

Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis

BMC research notes, 2012-07, Vol.5 (1), p.342-342, Article 342

2012

Volltextzugriff (PDF)

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease

Journal of the American College of Cardiology, 2012-06, Vol.59 (25), p.2338-2343

2012

Volltextzugriff (PDF)

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease: The Recovery Trial

Journal of the American College of Cardiology, 2012-06, Vol.59 (25), p.2338-2343

2012

Volltextzugriff (PDF)

RECOVERY OF PLATELET FUNCTION FOLLOWING DISCONTINUATION OF PRASUGREL OR CLOPIDOGREL MAINTENANCE DOSING IN ASPIRIN-TREATED SUBJECTS WITH STABLE CORONARY DISEASE: THE RECOVERY TRIAL

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E1636-E1636

2011

Volltextzugriff (PDF)

Troponin-I as a prognosticator of mortality in severe sepsis patients

Journal of critical care, 2010-06, Vol.25 (2), p.270-275

2010

Volltextzugriff (PDF)

Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis

Critical care medicine, 2010-01, Vol.38 (1), p.72-83

2010

Volltextzugriff (PDF)

Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)

Critical care (London, England), 2010-01, Vol.14 (6), p.R229-R229

2010

Volltextzugriff (PDF)

Response to Letter by Toni et al

Stroke (1970), 2008-10, Vol.39 (10)

2008

Volltextzugriff (PDF)

Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset : Analysis of data from the glycine antagonist in neuroprotection (GAIN) americas trial

Stroke (1970), 2007-10, Vol.38 (10), p.2706-2711

2007

Volltextzugriff (PDF)

USE OF ROUTINE BLOOD CULTURES IN PROTOCOLS FOR THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST.: 416

Critical care medicine, 2006-12, Vol.34 (12 Abstract supplement), p.A115-A115

2006

Volltextzugriff (PDF)

SEIZURES IN COMATOSE CARDIAC ARREST SURVIVORS RECEIVING THERAPEUTIC HYPOTHERMIA: 54

Critical care medicine, 2006-12, Vol.34, p.A14

2006

Volltextzugriff (PDF)

USE OF ROUTINE BLOOD CULTURES IN PROTOCOLS FOR THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST: 416

Critical care medicine, 2006-12, Vol.34, p.A115

2006

Volltextzugriff (PDF)

INDUCED HYPOTHERMIA THERAPY FOR SURVIVORS OF IN- AND OUT-OF-HOSPITAL CARDIAC ARREST − A RETROSPECTIVE REVIEW: 415

Critical care medicine, 2006-12, Vol.34, p.A115

2006

Volltextzugriff (PDF)

INDUCED HYPOTHERMIA THERAPY FOR SURVIVORS OF IN- AND OUT-OF-HOSPITAL CARDIAC ARREST − A RETROSPECTIVE REVIEW.: 415

Critical care medicine, 2006-12, Vol.34 (12 Abstract supplement), p.A115-A115

2006

Volltextzugriff (PDF)

SEIZURES IN COMATOSE CARDIAC ARREST SURVIVORS RECEIVING THERAPEUTIC HYPOTHERMIA.: 54

Critical care medicine, 2006-12, Vol.34 (12 Abstract supplement), p.A14-A14

2006

Volltextzugriff (PDF)

INDEPTH DATABASE OF SEVERE SEPSIS PATIENTS SHOWS FEWER CARDIAC EVENTS IN DROTRECOGIN ALFA (ACTIVATED) PATIENTS VS PLACEBO PATIENTS

Chest, 2005-10, Vol.128 (4), p.378S-378S

2005

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(62)
Berichte
(3)
Reviews
(1)

Sprache

Englisch
(66)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(39)
Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Male
(26)
Female
(21)
Aged
(18)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Middle Aged
(18)
Adult
(14)
General & Internal Medicine
(10)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(8)
Critical Care Medicine
(8)
Double-Blind Method
(8)
Intensive Care Medicine
(8)
Pharmacology. Drug Treatments
(7)
Treatment Outcome
(7)
Drug Administration Schedule
(6)
Emergency Medicine
(6)
Aged, 80 And Over
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a neonatal adverse event severity scale through a Delphi consensus approach

Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study

Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men

Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2

Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men: Ejaculatory Function

Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2%: Endocrinology

Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study

Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study

Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study

Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease: The Recovery Trial

RECOVERY OF PLATELET FUNCTION FOLLOWING DISCONTINUATION OF PRASUGREL OR CLOPIDOGREL MAINTENANCE DOSING IN ASPIRIN-TREATED SUBJECTS WITH STABLE CORONARY DISEASE: THE RECOVERY TRIAL

Troponin-I as a prognosticator of mortality in severe sepsis patients

Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis

Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)

Response to Letter by Toni et al

Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset : Analysis of data from the glycine antagonist in neuroprotection (GAIN) americas trial

USE OF ROUTINE BLOOD CULTURES IN PROTOCOLS FOR THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST.: 416

SEIZURES IN COMATOSE CARDIAC ARREST SURVIVORS RECEIVING THERAPEUTIC HYPOTHERMIA: 54

USE OF ROUTINE BLOOD CULTURES IN PROTOCOLS FOR THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST: 416

INDUCED HYPOTHERMIA THERAPY FOR SURVIVORS OF IN- AND OUT-OF-HOSPITAL CARDIAC ARREST − A RETROSPECTIVE REVIEW: 415

INDUCED HYPOTHERMIA THERAPY FOR SURVIVORS OF IN- AND OUT-OF-HOSPITAL CARDIAC ARREST − A RETROSPECTIVE REVIEW.: 415

SEIZURES IN COMATOSE CARDIAC ARREST SURVIVORS RECEIVING THERAPEUTIC HYPOTHERMIA.: 54

INDEPTH DATABASE OF SEVERE SEPSIS PATIENTS SHOWS FEWER CARDIAC EVENTS IN DROTRECOGIN ALFA (ACTIVATED) PATIENTS VS PLACEBO PATIENTS

Suchergebnisse filtern